Showing results (741-750 of 2,227) with videos related to
Sort By:
Pageof 223
Medical and Pediatric Oncology|December 7, 2000
Prognostic significance of EPHB6, EFNB2, and EFNB3 expressions in neuroblastomaX X Tang, H Zhao, M E Robinson, et al.Medical and Pediatric Oncology|December 7, 2000
Distinct properties of fenretinide and CD437 lead to synergistic responses with chemotherapeutic reagentsP E Lovat, M Ranalli, F Bernassola, et al.Medical and Pediatric Oncology|December 7, 2000
Differential expression in an antisense MYCN neuroblastoma modelM L Schmidt, A Lal, D DittmannMedical and Pediatric Oncology|July 24, 2001
Expression of Fas (APO-1/CD95) and Fas ligand (FasL) in human neuroblastomaN Gross, K Balmas, C Beretta Brognara, et al.Medical and Pediatric Oncology|July 24, 2001
Decreased wild-type full-length Et-A and -B receptors in neuroblastoma and Ewing sarcoma cellsP A Berry, Y F Zhang, N D Carter, et al.Medical and Pediatric Oncology|July 24, 2001
Distribution of natural antibody against human neuroblastoma among children with or without neuroblastomaM Fukuda, C Nozaki, Y Ishiguro, et al.Medical and Pediatric Oncology|July 24, 2001
Observation of untreated patients with neuroblastoma detected by mass screening: a "wait and see" pilot studyA Yoneda, T Oue, K Imura, et al.Medical and Pediatric Oncology|July 24, 2001
Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastomaK Horibe, M Fukuda, Y Miyajima, et al.Medical and Pediatric Oncology|July 24, 2001
Somatostatin receptor type 2 gene expression in neuroblastoma, measured by competitive RT-PCR, is related to patient survival and to somatostatin receptor imaging by indium -111-pentetreotideC Orlando, C C Raggi, L Bagnoni, et al.Medical and Pediatric Oncology|July 24, 2001
Localised and unresectable neuroblastoma in infants: excellent outcome with primary chemotherapy. Neuroblastoma Study Group, Société Française d'Oncologie PédiatriqueH Rubie, D Plantaz, C Coze, et al.Pageof 223